South Korean Government Decree on Antibiotics Won’t Impact U.S. Exports
South Korean Government Decree on Antibiotics Won’t Impact U.S. Exports
The South Korean government’s recent decision to ban the use of seven antibiotics in animal feed in 2009 will not affect U.S. beef and pork exports to South Korea.
The new law restricts the use of these seven antibiotics — Neomycin, Penicillin, Chlortetracycline, Colistin, Oxytetracycline, Lincomycin, and Bacitracin zinc — for Korean domestic production of animal feed. These antibiotics may still be used therapeutically in livestock, and the maximum residue level (MRL) standards for these antibiotics remain unchanged for domestic production and imported meat items.
FDA Seeking Public Comment on Draft Guidance on Genetically Engineered Animal Regulation
The U.S. Food and Drug Administration (FDA) today released for public comment draft guidance on the regulation of genetically engineered (GE) animals. The guidance document is intended to clarify the FDA’s regulatory authority, as well as the requirements and recommendations for producers of GE animals and products derived from GE animals.
Genetic engineering generally refers to the use of recombinant DNA (rDNA) techniques to introduce new characteristics or traits into an organism. Genetic engineering already is widely used in agriculture to make crops resistant to pests or herbicides. Genetic engineering also is used in animals for such purposes as developing traits that improve nutrition, contributing to faster growth or reducing emission levels of environmentally harmful substances, such as phosphate in manure.
Using the animal drug provisions of the Federal Food, Drug and Cosmetic Act (FD&C Act), the FDA’s Center for Veterinary Medicine has been working with the developers of GE animals to make them aware of their responsibilities to ensure that food from these animals does not enter the U.S. food supply unless the FDA has authorized such use.
The comment period on the draft guidance, titled “The Regulation of Genetically Engineered Animals Containing Heritable rDNA Constructs,” runs through Nov. 18, 2008. The 25-page document is available online.
Those interested in hearing a replay of the conference call conducted today by FDA can call 1-800-813-5534 (inside the United States) and 1-203-369-3348 (outside the United States). The replay will be available through 11:59 p.m. Thursday, Sept. 25, 2008.
South Korean Government Decree on Antibiotics Won’t Impact U.S. Exports
The South Korean government’s recent decision to ban the use of seven antibiotics in animal feed in 2009 will not affect U.S. beef and pork exports to South Korea.
The new law restricts the use of these seven antibiotics — Neomycin, Penicillin, Chlortetracycline, Colistin, Oxytetracycline, Lincomycin, and Bacitracin zinc — for Korean domestic production of animal feed. These antibiotics may still be used therapeutically in livestock, and the maximum residue level (MRL) standards for these antibiotics remain unchanged for domestic production and imported meat items.
FDA Seeking Public Comment on Draft Guidance on Genetically Engineered Animal Regulation
The U.S. Food and Drug Administration (FDA) today released for public comment draft guidance on the regulation of genetically engineered (GE) animals. The guidance document is intended to clarify the FDA’s regulatory authority, as well as the requirements and recommendations for producers of GE animals and products derived from GE animals.
Genetic engineering generally refers to the use of recombinant DNA (rDNA) techniques to introduce new characteristics or traits into an organism. Genetic engineering already is widely used in agriculture to make crops resistant to pests or herbicides. Genetic engineering also is used in animals for such purposes as developing traits that improve nutrition, contributing to faster growth or reducing emission levels of environmentally harmful substances, such as phosphate in manure.
Using the animal drug provisions of the Federal Food, Drug and Cosmetic Act (FD&C Act), the FDA’s Center for Veterinary Medicine has been working with the developers of GE animals to make them aware of their responsibilities to ensure that food from these animals does not enter the U.S. food supply unless the FDA has authorized such use.
The comment period on the draft guidance, titled “The Regulation of Genetically Engineered Animals Containing Heritable rDNA Constructs,” runs through Nov. 18, 2008. The 25-page document is available online.
Those interested in hearing a replay of the conference call conducted today by FDA can call 1-800-813-5534 (inside the United States) and 1-203-369-3348 (outside the United States). The replay will be available through 11:59 p.m. Thursday, Sept. 25, 2008.